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S U M M A R Y
Objective: To investigate the diagnostic value of abdominal ultrasound in HIV-positive inpatients in a
rural African setting.
Methods: Thiswas a prospective case series over 3months of adult HIV-positive patientswith symptoms
suggestive of abdominal tuberculosis (TB). Diagnostic ultrasound was performed for all patients:
sonographic criteria included abdominal lymph node enlargement (>1.5 cm) and focal splenic lesions;
ascites was a supportive ﬁnding. Further diagnostic studies, e.g., aspiration or biopsy were not routinely
performed. TB treatment was initiated on the basis of clinical and sonographic features. The patients
were contacted after 4 months to evaluate the clinical outcome.
Results: One hundred and eighty adult HIV-positive patients were screened; 30 (16.7%) showed
sonographic signs of abdominal TB. The median CD4 count was 78 cells/mm3. Presenting symptoms
were weight loss (86.7%), abdominal pain (76.7%), and diarrhea (60%). Abdominal lymph node
enlargement was the diagnostic ﬁnding in almost all cases (96.7%); hypoechoic lesions of the spleen
were seen in 50% and ascites in 73.3%. Follow-up information was available for 25 patients: 24% had died
and the remaining 76% reported symptomatic improvement and weight gain.
Conclusions: Characteristic sonographic features of abdominal TB are common in HIV-infected
inpatients in a rural African setting. Ultrasound should be introduced into clinical algorithms for the
diagnosis of extrapulmonary TB.
 2010 International Society for Infectious Diseases. Published by Elsevier Ltd.
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The convergence of the HIV and tuberculosis (TB) epidemics in
Southern Africa has contributed to a signiﬁcant increase in
reported cases of TB and especially of extrapulmonary TB (EPTB).1
Abdominal TB is a frequent localization of EPTB in HIV-positive
patients.2 Abdominal symptoms are common at all stages of HIV
infection, but particularly at advanced stages of immunosuppres-
sion. It can be challenging in a setting with limited diagnostics to
differentiate between symptoms caused by HIV itself and
symptoms related to opportunistic infection or neoplasm.3 The
lack of advanced imaging techniques such as computed tomo-
graphy (CT) and magnetic resonance imaging (MRI), and the
limited use of cytology, histology, and cultures, compel physicians
to make treatment decisions based on history, clinical examina-§ Presented in part at the 4th Southern African AIDS Conference, March 31–April
3, 2009, Durban, South Africa (abstract 278, poster presentation).
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doi:10.1016/j.ijid.2009.11.030tion, and basic laboratory tests. Simple non-invasive diagnostic
tools are urgently required in resource-limited rural settings. In the
rural district hospital setting, ultrasound is often the most
commonly available imaging modality.
World Health Organization guidelines contain criteria for the
diagnosis of some forms of EPTB, but do not explicitly include
abdominal TB.4 Typical ultrasound ﬁndings of abdominal TB have
been described in low HIV prevalence settings.5–7 They include
retroperitoneal and mesenteric lymphadenopathy with node
diameter greater than 1.5 cm,multiple splenic hypoechoic nodules
between 0.5 cm and 1 cm, and patterns of ascites. Hepatic
hyperechoic nodules, retroperitoneal abscess, and bowel wall
thickening are less frequently described.5 Although similar
ultrasound ﬁndings of lymphadenopathy and splenomegaly are
described in African HIV patients, the role of TB co-infection has
rarely been explored.8,9 One recent report from Zambia described
typical ﬁndings of abdominal TB in a high proportion of individuals
with low CD4 counts and abdominal symptoms.10 We sought to
investigate the role of ultrasound in the diagnosis of abdominal TB
in a rural district hospital in an area of high HIV and TB prevalence.Ltd. Open access under CC BY license.
Table 1




Age, mean  SD, years 318
CD4
Median (range), cells/mm3 78 (6–408)
<200 cells/mm3 91% (95% CI 81–100%)
<50 cells/mm3 41% (95% CI 23–59%)
BMI, median (range), kg/m2 19.9 (13.3–34.7)
SD, standard deviation; CI, conﬁdence interval; BMI, body mass index.
Table 2
Symptoms reported by patients with abdominal TB (N=29a)
Symptoms n % 95% CI
Weight loss only 3 10% 0–21%
Abdominal pain only 3 10% 0–21%
Weight loss and abdominal pain 5 16.7% 3–31%
Weight loss and diarrhea 3 10% 0–21%
Weight loss and abdominal pain and diarrhea 15 50% 31–69%
CI, conﬁdence interval.
a One patient had only abdominal distension with no further symptoms.
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2.1. Study setting
Hlabisa Hospital and its 16 primary healthcare (PHC) clinics
serve the Hlabisa sub-district in northern KwaZulu-Natal, South
Africa. In an area of approximately 1400 km2 lives a mainly Zulu-
speaking population of approximately 228 000. The sub-district is
predominantly rural with one peri-urban area.
The hospital has 300 beds and is staffed by nine to 12
physicians. Approximately 60 000 outpatient visits and 6500
admissions with an average length of stay of six days occur per
year. Care for internal medicine patients is delivered in separate
male, female, and TB wards. The diagnostic services available are
limited. X-ray and ultrasound can be used as imaging
modalities. Basic hematology and biochemistry are available
in the hospital laboratory; in addition microscopy of urine and
cerebrospinal ﬂuid, TB microscopy, and CD4 counts are done. TB
culture and histology are available at the provincial reference
hospital, but results rarely inﬂuence acute clinical management.
Patients can be referred to the provincial hospital for CT and MRI
scans, but the distance of approximately 100 km, as well as the
limited appointments available, restrict this option to selected
cases.
The HIV prevalence in the adult resident population (aged 15–
49 years) is 21.5%.11 The TB notiﬁcation rate in Hlabisa sub-district
has increased from approximately 700 per 100 000 persons in 2003
to 1700 per 100 000 persons in 2008; the number of reported cases
of EPTB has risen over 10-fold from 41 to 522 in the same time-
period (personal communication, Department of Health, Umkha-
nyakude District). The HIV co-infection rate for TB patients is
approximately 76%.12 The TB Control Programme adheres to
national guidelines: treatment is initiated by nurses for smear-
positive pulmonary disease; the diagnosis of smear-negative
pulmonary or EPTB is made by a physician on the basis of clinical
or radiological ﬁndings (rarely with culture or histological
conﬁrmation).13 This occurs in hospital, at the central TB clinic,
or by physicians serving the decentralized HIV treatment and care
program. Patients can be referred to hospital from the clinics for
further diagnostic assessment if required.
2.2. Study procedure
Patients were enrolled into the study from June to August
2008. All participants were adult (18 years) HIV-positive
patients admitted to the general medical wards. Patients from
the tuberculosis ward were not included as they were invariably
known TB cases admitted to the ward to receive streptomycin
injections or multidrug-resistant TB treatment. Patients were
initially seen by admitting hospital staff and were referred to the
study if they reported one or more of the following clinical
symptoms: abdominal pain, abdominal distension, diarrhea, or
weight loss. Patients were subsequently interviewed and
examined by the study physician assisted by a nurse (who also
translated from isiZulu). A standardized data sheet was used to
collect patient information, including clinical symptoms,
laboratory results, chest X-ray (CXR) results, CD4 cell count,
and history of antiretroviral therapy (ART) use. Patients were
included if their HIV diagnosis was known at the time of hospital
admission or if the diagnosis was made during the inpatient
episode.
There is no established ultrasound department at the study
hospital and all exams were performed by the study physician
using a Toshiba Just Vision 400 Model SSA-325A with a 3.5 MHz
abdominal probe in a room adjacent to the X-ray facilities. All
ultrasound studies were performed by a physician trained inabdominal ultrasound with more than 10 years of experience in
the technique. Abdominal sonographic ﬁndings were then
recorded on the data sheet.
Abdominal TB was diagnosed on the basis of typical ﬁndings of
lymph node enlargement greater than 1.5 cm and/or focal splenic
lesions. Ascites was noted as further supportive evidence. If only
ascites was present this was not considered diagnostic and the
patient was not included in the study group; further investigations
for alternative diagnoses (e.g., cirrhosis, congestive heart failure)
were undertaken. After TB diagnosis, patients were treated
according to the South African national TB guidelines:13 initial
treatment for new cases includes rifampin, isoniazid, pyrazina-
mide and ethambutol for 2 months, followed by rifampin and
isoniazid for 4 months.
If patients were not already on ART theywere offered treatment
according to South African national guidelines (EPTB is a stage 4
condition and ART is indicated regardless of CD4 cell count).14 The
ﬁrst-line ART regimen includes stavudine, lamivudine, and either
efavirenz or nevirapine (efavirenz preferred in TB co-infection).
Follow-up information was obtained at approximately 4 months
by the TB coordinator who contacted the patient by phone and
asked a series of questions regarding weight gain, resolution of
symptoms (abdominal pain, diarrhea), andwhether or not ART had
been commenced.
Ethical approval was obtained from the Hlabisa Hospital Ethics
Committee. Verbal consent was obtained from all patients; this
was considered adequate as all procedures were considered part of
routine clinical care.
3. Results
One hundred and eighty adult HIV-positive patients with
symptoms were screened; amongst these, 30 (16.7%) fulﬁlled the
case deﬁnition of abdominal TB based on sonographic features.
Patients included in the analysis were between 18 and 49 years of
age and 53% were women. The median CD4 count was 78 cells/
mm3 (91% with CD4 <200 cells/mm3; 41% with CD4 <50 cells/
mm3). Three patients were on ART at the time of the examination
(for 1 week, 1 month, and 3 months, respectively). The median
body-mass index was 19.9 kg/m2 (range 13.3–34.7) (Table 1). The
clinical symptoms of the patients are summarized in Table 2; 86.7%
presented with weight loss, 76.7% with abdominal pain, and 60%
Table 3
Laboratory results in patients with abdominal TB
Laboratory test Valuea 95% CI
Hb, g/dl 7.42.0
<8 g/dl 65% 45–85%
ALT, U/l 4733
>60 U/l 23% 5–41%
GGT, U/l 12093
>62 U/l 65% 44–86%
Bilirubin (total), mmol/l 1720
>17.0mmol/l 33% 12–54%
Albumin, g/l 163.3
<32 g/l 100% 95–100%
Total protein, g/l 7114
>80 g/l 32% 12–52%
CI, conﬁdence interval; Hb, hemoglobin; ALT, alanine aminotransferase; GGT,
gamma-glutamyl transferase.
a Values are mean standard deviation.
Table 4
Sonographic ﬁndings in abdominal TB patients (N=30)
Sonographic ﬁndings n % 95% CI
Lymph nodes only 4 13% 1–25%
Splenic lesions and ascites 1 3% 0–9%
Lymph nodes and ascites 11 37% 19–55%
Lymph nodes and splenic lesions 4 13% 1–25%
Lymph nodes and splenic lesions and ascites 10 33% 16–50%
CI, conﬁdence interval.
Figure 1. Sonographic image of (a) enlarged lymph nodes in the periportal area; (b)
focal lesions in the spleen of approximately 3 mm in diameter; (c) focal lesions in
the spleen of approximately 10 mm in diameter.
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hospital admission are displayed in Table 3.
Abdominal lymph node enlargement was a common ﬁnding,
present in almost all cases (29/30, 96.7%). Hypoechoic lesions of
the spleen were seen in 15/30 (50%) and ascites in 22/30 (73.3%) of
the patients. The combinations of ﬁndings are shown in Table 4.
Examples of abdominal lymphadenopathy and microabscesses in
the spleen are shown in Figure 1.
A CXR was available for assessment from 23 patients: 18
(78.3%) demonstrated ﬁndings compatible with TB, including ﬁve
(21.7%) that displayed a miliary pattern; ﬁve (21.7%) had a normal
CXR.
Telephonic follow-up information was available for 25 patients
a mean period of 17 weeks (range 12–23 weeks) after starting TB
treatment. Six patients had died (24%), and the median time
between start of TB treatment and death was 2 weeks (range 0–17
weeks). The remaining 19 patients (76%) were still taking TB
treatment and reported clinical improvement and weight gain. All
but one of the 16 surviving patients not already on ART had started
this by the time of follow-up.
4. Discussion
Ultrasound is safe, portable, inexpensive, non-invasive, and can
investigate most organs affected in HIV-infected patients.15 These
features are critical for investigation of patients in resource-
limited settings compared to patients in industrialized countries
with a preponderance of CT and MRI scanners, and with trained
radiologists to guide the interpretation. Sonographic ﬁndings
suggestive of abdominal TB, especially in HIV-infected patients,
have been described in patient populations of different racial
backgrounds and have been suggested as part of the work-up in
HIV-infected patients with fever of unknown origin.5–7,16 Despite
the fact that suggestive ﬁndings have been reported in large
ultrasound series in African patients, it is unclear whether in the
face of other causes of lymphadenopathy the ﬁndings are speciﬁc
enough to be considered diagnostic.8,9 The common dilemma forthe physician faced with a heavily immunosuppressed patient in
this setting is whether there is evidence of TB and a need for
treatment or whether to start ART. This is particularly challenging
as almost one in four patients still initiate ART with a CD4 count
<50 cells/mm3.17 Commencement of ART without adequate
exclusion of TB risks the development of immune reconstitution
inﬂammatory syndrome (IRIS) with consequent morbidity and
mortality.18
In our patient series we found that ultrasound is a feasible
technique to add weight to a diagnosis of abdominal TB in HIV-
infected patients. Most patients have severe immunosuppression
and report symptoms of weight loss, abdominal pain, and diarrhea,
or a combination thereof. The pre-test probability for TB is often
relatively high given the extremely high TB incidence in this
community. Laboratory investigations in our patients frequently
show anemia, most probably anemia of chronic disease related to
both HIV and TB. All patients had a reduced albumin, most
probably secondary to malnutrition and possibly malabsorption
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were elevated in a large proportion of patients, suggesting
involvement of the liver either as diffuse inﬁltration or with
obstructive disease of the small bile ducts (no visible biliary
dilatation was found in the ultrasound exams).
In our series, scanning was made easier by the high proportion
of underweight patients, as interference by fat and air is minimal.
Abdominal TB was diagnosed by ultrasound without further
invasive diagnostic steps; treatmentwas started on the basis of the
imaging ﬁndings alone. In themajority of patients the approach led
to a favorable outcome suggested by weight gain and cessation of
symptoms. Of the six patients who died, three died within a week
of the ultrasound exam, suggesting they died due to the severity of
their disease. It is interesting to note that three patients were on
ART at the time of the diagnosis. All of them started within a short
period before the examination, suggesting IRIS as a potential
contributory factor unmasking underlying abdominal TB.
Limitations of our study include the lack of microbiological or
histological conﬁrmation of abdominal TB. Fine-needle aspiration
biopsies are restricted for suspected drug-resistant cases and for
clinical cases that show atypical signs (e.g., solid organ inﬁltration
suggestive of lymphoma). Unfortunately, biopsy needles are
scarce and histology and TB culture are not performed on site, but
rather are sent to the central histology laboratory in Durban, and
results rarely contribute to acute management. One has to
consider other causes of abdominal lymphadenopathy. HIV itself
can cause abdominal lymphadenopathy throughout the conti-
nuum of HIV infection, but this is not usually accompanied by
other features.19 Kaposi’s sarcoma (KS) is prevalent in the patient
population in Hlabisa sub-district, although most patients with
disseminated visceral KS have signiﬁcant skin involvement,
which none of our patient group exhibited. Lymphoma is an
additional neoplasm that needs to be considered in the
differential diagnosis. Infections with non-tuberculous mycobac-
teria (NTM) cannot be ruled out as a cause, but they are rarely
diagnosed due to a lack of mycobacterial blood cultures; the
prevalence of NTM disease in this setting is therefore unknown.
Nevertheless, in a series of 31 patients, NTM were reported to
cause abdominal adenopathy less frequently thanMycobacterium
tuberculosis, and splenic microabscesses were not seen with
NTM.20
We included only patients with symptoms related to the
abdomen and did not include patients with isolated fever of
unknown origin, so there is a possibility we may have missed
additional cases of abdominal TB, particularly those at an earlier,
less symptomatic stage. Our exclusion of individuals with ascites
alone was based on our experience in this setting that ascites
without ﬁbrinous strands and with no other diagnostic signs can
usually be attributed to chronic heart failure or liver failure. We
may havemisclassiﬁed some patients by this exclusion, and ascitic
ﬂuid culture for Mycobacterium tuberculosis is not routinely
practiced here due to the cost and the relatively low yield (less
than 20% in most series10). Our results are also hampered by the
lack of information on those screened but not diagnosed with
abdominal TB. We lost ﬁve out of our 30 patients to follow-up,
which is most likely due to communication difﬁculties and
patients with a lack of resources to be able to afford either a
cell or land-based telephone.
Further research is needed to assess the impact of a
standardized ultrasound screening as part of work-up before
starting ART, especially for those with advanced immunosuppres-
sion. It would further be interesting to evaluate, if in a fraction of
patients the ﬁndings of abdominal TB would render CXR
unnecessary. Portable ultrasound machines make it possible to
examine patients in the PHC clinic setting, whichwould reduce the
need (and the expenses) of patients traveling to hospital for CXR.As trained sonographers are scarce in the resource-limited setting,
the possibility of training a wider range of medical doctors or
clinical assistants in rural hospitals in a limited and focused
assessment with sonography, similar to the FAST technique
(focused abdominal sonography for trauma) widely used in
emergencymedicine, should be investigated.21 Preliminary results
of a training course around focused assessment with sonography
for HIV/TB (‘FASH’) have been reported by our group.22 This
research into the use of ultrasound obviously does not obviate the
need for improved TB diagnostics, particularly point-of-care
diagnostics.
5. Conclusions
Abdominal ultrasound is an effective diagnostic tool to identify
lymphadenopathy and focal splenic lesions suggestive of abdomi-
nal TB in HIV-infected patients. As a diagnostic gold standard is not
available, the sensitivity and speciﬁcity of the method are difﬁcult
to determine. Nevertheless, our patient series suggests that
ultrasound-based diagnosis followed by TB treatment beneﬁts
the vast majority of patients and is a feasible approach when
resources for further invasive diagnostics are limited. If imple-
mented on a broader scale, ultrasoundwould assist physicians and
other healthcare workers in making more appropriate treatment
decisions instead of having to use the ‘treat ﬁrst, think later’
approach, thus having the potential to save precious time and
resources. Ultrasound has been shown to be a useful and
ﬁnancially affordable adjunct to clinical diagnosis in a wide
variety of pathologies at the district healthcare level.23 Abdominal
ultrasound should be introduced into clinical algorithms for the
diagnosis of EPTB.
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